OM1 is a company that specializes in personalized medicine, evidence generation, and research platforms. It offers PhenOM, a digital phenotyping platform trained using a repository of claims and data coverings as well as used in earlier detection of disease. The company provides solutions in the areas of immunology, mental health and neuroscience, cardiometabolic, dermatology, gastroenterology, etc.